Novel investigations highlight Namilumab, a humanized antibody aimed CSF2 (Colony Stimulating Factor 2), also known as GM-CSF. This innovative therapeutic strategy is showing potential in managing https://bookmarks-hit.com/story25722749/namilumab-a-deep-dive-into-the-csf2-antibody-treatment